The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Antiparasitic Drugs Global Market Report 2023, the antiparasitic drugs market is expected to show promising growth in the forecast period.

The antiparasitic drugs market has exhibited substantial growth in recent years, witnessing a surge from $22.47 billion in 2023 to an estimated $24.06 billion in 2024, reflecting a Compound Annual Growth Rate (CAGR) of 7.1%. This growth, rooted in the historic period, is attributed to the prevalence of parasitic infections, increased resistance to existing treatments, global health initiatives, and a growing demand for more effective and tolerable vaccines.

Anticipated Strong Growth: Projections for the Future
Forecasted Growth in the Next Few Years:

• The antiparasitic drugs market is poised for continued expansion, reaching $31.19 billion in 2028.
• The forecasted Compound Annual Growth Rate (CAGR) for this period is 6.7%.

Drivers of Future Growth:

• Emerging parasitic threats and climate change-related vector-borne diseases.
• Increased emphasis on global health security and enhanced access to healthcare.

Trends Shaping the Future:

• Advances in drug development.
• Targeted therapies and combination therapies.
• Growing influence of public-private partnerships.
• Integration of telemedicine and remote diagnosis.

Parasitic Menace: High Prevalence Fuels Market Growth
The Impact of Parasitic Infections:

• Parasitic infections caused by microscopic parasites or larger organisms are on the rise.
• Antiparasitic drugs play a crucial role in managing and controlling these infections.
• Improved health outcomes and reduced disease burden result from effective antiparasitic interventions.

Statistics Speak Volumes:

• In August 2021, a study by the National Library of Medicine revealed a significant prevalence of intestinal parasites.
• 3% of participants in the study exhibited intestinal parasites, with Entamoeba histolytica being the most prevalent (33.3%).

View More On The Antiparasitic Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/antiparasitic-drugs-global-market-report

Industry Leaders: Driving Growth in the Antiparasitic Drugs Market
Key Players in the Market:

• Pfizer Inc., Johnson & Johnson, Cadila Pharmaceuticals, Merck & Co. Inc., and other major players are instrumental in market growth.
• Established pharmaceutical companies contribute to the market’s robust landscape.

Striving for Improved Solutions:

• ParaPRO LLC’s Natroba marks a significant milestone as the first antiparasitic product approved by the U.S. FDA for scabies treatment.
• The product’s active ingredient, Spinosad, uniquely targets mites at the site of infestation without penetrating deeply.

Strategic Acquisitions: Orion Corporation’s Expansion in Animal Health
Inovet BV’s Animal Health Business Acquisition:

• Orion Corporation’s acquisition of Inovet BV’s animal health business for $141 million in June 2022.
• The move strengthens Orion’s geographical presence in Western Europe and export markets.
• Acquisition includes a production unit specializing in veterinary medicine manufacturing.

Market Segmentation: Understanding the Landscape

1) By Product Type:

• Segmentation includes anthelmintics, antiprotozoals, ectoparasiticides, and other products.

2) By Treatment:

• Avermectins, bezimidazoles, pyrimidines, organophosphates, and imidazoles/thiazoles form treatment categories.

3) By Route of Administration:

• Options include oral, injectable, and topical administration.

4) By End User:

• Utilization in hospitals, homecare, specialty clinics, and other end-user settings.

Regional Dynamics: North America Leading, Asia-Pacific Surging Ahead
North America’s Dominance:

• In 2023, North America emerged as the largest region in the antiparasitic drugs market.
• The region’s prominence underscores its significant contribution to overall market growth.

Asia-Pacific’s Rapid Growth:

• Asia-Pacific is projected to be the fastest-growing region in the forecast period.
• The region reflects a burgeoning market with increasing demand for antiparasitic drugs.

Request A Sample Of The Global Antiparasitic Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12927&type=smp

The Antiparasitic Drugs Global Market Report 2023  offers a comprehensive overview on the antiparasitic drugs market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the antiparasitic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Antiparasitic Drugs Market Include:
1. Antiparasitic Drugs Market Executive Summary
2. Antiparasitic Drugs Market Segments
3. Antiparasitic Drugs Market Size And Antiparasitic Drugs Market Growth Rate
4. Key Antiparasitic Drugs Market Trends
5. Major Antiparasitic Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Antiparasitic Drugs Market
26. Top Antiparasitic Drugs Companies
27. Antiparasitic Drugs Market Opportunities And Strategies
28. Antiparasitic Drugs Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
Glycopeptide Antibiotics Global Market Report 2023
Peptide Antibiotics Global Market Report 2023
Inhaled Antibiotics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model